Dengue Hemorrhagic Fever (DHF)

What is Dengue Hemorrhagic Fever (DHF)?

Dengue Hemorrhagic Fever is a serious complication of dengue virus infection. It causes blood vessels to become damaged and leaky. This leads to bleeding, low platelet counts, and fluid buildup in the body.

DHF usually develops in people who get infected with dengue virus a second time. The immune system overreacts during the second infection. This can cause dangerous inflammation and bleeding. Without prompt medical treatment, DHF can progress to dengue shock syndrome, which can be life threatening.

This condition is most common in tropical and subtropical regions. It affects children more often than adults in areas where dengue is widespread. Early recognition and proper medical care can significantly improve outcomes.

Dengue Fever Antibodies (IgG, IgM)

Detect dengue infection early for quick treatment
Confirm if past dengue exposure affects you
Clarify unexplained fever and symptoms fast

^$740

Symptoms

High fever lasting 2 to 7 days
Severe abdominal pain
Persistent vomiting
Bleeding from nose or gums
Blood in vomit or stool
Bruising easily or red spots on skin
Cold or clammy skin
Rapid breathing or difficulty breathing
Restlessness or irritability
Extreme fatigue or weakness

Early symptoms of DHF often resemble regular dengue fever. Warning signs typically appear 3 to 7 days after fever begins. Immediate medical attention is critical when bleeding or severe abdominal pain develops.

Causes and risk factors

DHF develops when someone who had dengue infection in the past gets infected again with a different dengue virus type. There are four distinct types of dengue virus. The immune system remembers the first infection and overreacts to the second one. This creates an immune response that damages blood vessels instead of protecting the body.

Risk factors include living in or traveling to areas where dengue is common, such as Southeast Asia, Latin America, and the Caribbean. Previous dengue infection is the strongest risk factor. Children under 15 years old in dengue-affected regions have higher risk. Certain genetic factors may also make some people more vulnerable to severe dengue complications.

How it's diagnosed

Doctors diagnose DHF based on symptoms, physical examination, and laboratory tests. Blood tests check platelet counts, which drop significantly in DHF. Tests also measure hematocrit levels to detect blood concentration from leaking vessels. Dengue Fever Antibodies tests can identify dengue infection and distinguish between primary and secondary infections.

A high level of IgG antibodies early in illness suggests a secondary infection, which increases DHF risk. IgM antibodies indicate recent infection. Specialized dengue testing may be needed beyond standard blood panels. Talk to your doctor about appropriate testing if you develop symptoms after traveling to dengue-affected areas or if you live in regions where dengue is common.

Treatment options

Hospitalization for close monitoring and supportive care
Intravenous fluids to maintain blood pressure and prevent shock
Blood transfusions if severe bleeding occurs
Platelet transfusions in cases of extremely low platelet counts
Oxygen therapy if breathing becomes difficult
Careful monitoring of vital signs and blood counts
Rest and avoiding medications that can increase bleeding risk
Acetaminophen for fever, avoiding aspirin and ibuprofen

There is no specific antiviral treatment for DHF. Medical care focuses on managing symptoms and preventing complications. Most people recover with proper hospital care. Early treatment greatly reduces the risk of death from this condition.

Frequently asked questions

Dengue fever causes high fever, headache, and body pain but usually resolves on its own. Dengue Hemorrhagic Fever is a severe complication with bleeding, leaking blood vessels, and dangerously low platelet counts. DHF requires immediate hospital care and can be life threatening without treatment.

About 1 to 5 percent of people with dengue infection develop DHF. It occurs most often in children under 15 in areas where dengue is widespread. Secondary infections with different dengue virus types carry the highest risk of developing this severe complication.

DHF is rare during first dengue infections but possible. The condition develops much more frequently during second infections with a different dengue virus type. Previous dengue exposure primes the immune system to overreact during subsequent infections.

Warning signs include severe abdominal pain, persistent vomiting, bleeding from gums or nose, and blood in vomit or stool. Cold skin, rapid breathing, extreme fatigue, and restlessness are also red flags. These symptoms typically appear 3 to 7 days after fever starts and require immediate medical attention.

Doctors use blood tests to check platelet counts and hematocrit levels. Dengue antibody tests identify the virus and can show if it is a secondary infection. Clinical symptoms and physical examination findings help confirm the diagnosis. Specialized dengue testing may be needed in some cases.

With proper medical care, more than 95 percent of people survive DHF. Early recognition and hospital treatment greatly improve outcomes. Without treatment, the mortality rate can reach 20 percent or higher. Prompt medical attention when warning signs appear is critical.

Most people recover within 1 to 2 weeks with proper hospital care. The critical phase lasts about 24 to 48 hours. Full recovery may take several weeks as the body rebuilds strength and blood counts return to normal.

Preventing mosquito bites is the best protection against dengue and DHF. Use insect repellent, wear long sleeves and pants, and eliminate standing water around your home. Some countries offer dengue vaccines, which may help reduce severe complications in people with previous dengue infection.

Some dengue vaccines are available in certain countries. These vaccines work best in people who already had dengue infection at least once. The vaccine may reduce the risk of severe complications like DHF during future infections. Talk to your doctor about vaccine availability if you live in or travel to dengue-affected areas.

Testing for dengue antibodies can show if you had previous dengue infection, which increases your risk of DHF during future infections. This information helps you and your doctor stay alert for warning signs if you develop fever. Testing is most useful when you have symptoms or after potential exposure to dengue virus.